Surmodics Cash on Hand 2010-2025 | SRDX
Surmodics cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Surmodics Annual Cash on Hand (Millions of US $) |
2024 |
$40 |
2023 |
$45 |
2022 |
$19 |
2021 |
$39 |
2020 |
$61 |
2019 |
$55 |
2018 |
$65 |
2017 |
$48 |
2016 |
$47 |
2015 |
$56 |
2014 |
$47 |
2013 |
$26 |
2012 |
$30 |
2011 |
$38 |
2010 |
$20 |
2009 |
$21 |
Surmodics Quarterly Cash on Hand (Millions of US $) |
2025-03-31 |
$31 |
2024-12-31 |
$30 |
2024-09-30 |
$40 |
2024-06-30 |
$38 |
2024-03-31 |
$41 |
2023-12-31 |
$35 |
2023-09-30 |
$45 |
2023-06-30 |
$45 |
2023-03-31 |
$19 |
2022-12-31 |
$26 |
2022-09-30 |
$19 |
2022-06-30 |
$22 |
2022-03-31 |
$27 |
2021-12-31 |
$32 |
2021-09-30 |
$39 |
2021-06-30 |
$68 |
2021-03-31 |
$66 |
2020-12-31 |
$54 |
2020-09-30 |
$61 |
2020-06-30 |
$61 |
2020-03-31 |
$48 |
2019-12-31 |
$48 |
2019-09-30 |
$55 |
2019-06-30 |
$45 |
2019-03-31 |
$46 |
2018-12-31 |
$46 |
2018-09-30 |
$65 |
2018-06-30 |
$62 |
2018-03-31 |
$66 |
2017-12-31 |
$47 |
2017-09-30 |
$48 |
2017-06-30 |
$44 |
2017-03-31 |
$46 |
2016-12-31 |
$45 |
2016-09-30 |
$47 |
2016-06-30 |
$44 |
2016-03-31 |
$40 |
2015-12-31 |
$43 |
2015-09-30 |
$56 |
2015-06-30 |
$54 |
2015-03-31 |
$49 |
2014-12-31 |
$31 |
2014-09-30 |
$47 |
2014-06-30 |
$41 |
2014-03-31 |
$34 |
2013-12-31 |
$23 |
2013-09-30 |
$26 |
2013-06-30 |
$28 |
2013-03-31 |
$36 |
2012-12-31 |
$31 |
2012-09-30 |
$30 |
2012-06-30 |
$79 |
2012-03-31 |
$74 |
2011-12-31 |
$63 |
2011-09-30 |
$38 |
2011-06-30 |
$34 |
2011-03-31 |
$27 |
2010-12-31 |
$24 |
2010-09-30 |
$20 |
2010-06-30 |
$22 |
2010-03-31 |
$19 |
2009-12-31 |
$19 |
2009-09-30 |
$21 |
2009-06-30 |
$22 |
2009-03-31 |
$14 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$0.398B |
$0.126B |
Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
|